Your browser doesn't support javascript.
loading
From bench to patient: model systems in drug discovery.
Breyer, Matthew D; Look, A Thomas; Cifra, Alessandra.
Afiliação
  • Breyer MD; Eli Lilly and Company, Indianapolis, IN 46285, USA breyer_matthew@lilly.com thomas_look@dfci.harvard.edu.
  • Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 01864, USA breyer_matthew@lilly.com thomas_look@dfci.harvard.edu.
  • Cifra A; Disease Models & Mechanisms, The Company of Biologists, Bidder Building, Station Road, Histon, Cambridgeshire, CB24 9LF, UK.
Dis Model Mech ; 8(10): 1171-4, 2015 Oct 01.
Article em En | MEDLINE | ID: mdl-26438689
Model systems, including laboratory animals, microorganisms, and cell- and tissue-based systems, are central to the discovery and development of new and better drugs for the treatment of human disease. In this issue, Disease Models & Mechanisms launches a Special Collection that illustrates the contribution of model systems to drug discovery and optimisation across multiple disease areas. This collection includes reviews, Editorials, interviews with leading scientists with a foot in both academia and industry, and original research articles reporting new and important insights into disease therapeutics. This Editorial provides a summary of the collection's current contents, highlighting the impact of multiple model systems in moving new discoveries from the laboratory bench to the patients' bedsides.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Pesquisa Translacional Biomédica / Modelos Biológicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Pesquisa Translacional Biomédica / Modelos Biológicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article